Company / CapEx per Share
Sarepta Therapeutics CapEx per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest CapEx per Share
$1.05
FY2025
5-year range
$0.48 / $1.46
FY2021-FY2025
Trend
-28.0%
vs FY2024
Sector context
#13 of 192
Health Care
What the data says
Among 192 Health Care companies, Sarepta Therapeutics is in the top 7% for capex per share. CapEx per Share has fluctuated over the past 10 years, ranging from $0.12 in FY2016 to $1.46 in FY2024.
Based on SEC 10-K filings.
1.05 in FY2025 with a 5-year CAGR of +5.3%. Top quartile in the Health Care sector.
Improved from $0.87 to $1.05 over the past 2 years.
Health Care sector context is included.
CapEx per Share over time
Growth rates
- 3-Year CAGR
- +3.7%
- 5-Year CAGR
- +5.3%
- 10-Year CAGR
- -
Sector benchmark
Top 7% in Health CareTop 7% of 192This company $1.05 Sector average $3.54
▼
-70.3% below sector average
Key checks
Key Insights
- In FY2025, capex per share decreased 28.0% year-over-year.
- Ranks #13 out of 192 companies in the Health Care sector.
- Peak capex per share was recorded in FY2024.
- Lowest capex per share in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score -0.70 (distress zone, below 1.8 threshold)
- Negative profit margin: -11.3%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | CapEx per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.05 | -28.0% |
| FY2024 | $1.46 | +68.9% |
| FY2023 | $0.87 | -8.3% |
| FY2022 | $0.94 | +94.6% |
| FY2021 | $0.48 | -40.4% |
| FY2020 | $0.81 | +381.8% |
| FY2019 | $0.17 | -82.1% |
| FY2018 | $0.94 | +330.7% |
| FY2017 | $0.22 | +87.2% |
| FY2016 | $0.12 | +45.5% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026